Home › Funds › Connective Capital Management, LLC › LCTX

Connective Capital Management, LLC position in LCTX

LINEAGE CELL THERAPEUTICS IN · Health Care

Connective Capital Management, LLC reported holding 293,624 shares of LCTX (LINEAGE CELL THERAPEUTICS IN) in its Q3 2026 13F filing — a position valued at US$281K, representing 0.21% of its reported portfolio and ranking #47 among its reported holdings. Connective Capital Management, LLC first reported this position in Q3 2026.

Latest position (Q3 2026)293.62K sh
Reported value held$280.62K
Portfolio Weight0.21%
First reportedQ3 2026
Last changeNew
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Connective Capital Management, LLC's LCTX position evolved

Connective Capital Management, LLC first disclosed a stake in LCTX in Q3 2026 at 293,624 shares (US$281K).

Quarter by quarter

QuarterSharesValueChange
Q3 2026 293.62K $280.62K New

About LCTX and 13F data

LCTX (LINEAGE CELL THERAPEUTICS IN) is a Health Care company. 28 other funds we track also report a position in LCTX — the largest reported positions include BROADWOOD CAPITAL INC (US$47.4M), Defender Capital, LLC. (US$6.4M), RAFFLES ASSOCIATES LP (US$5.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LCTX

All LCTX fund holders →

FAQ

How long has Connective Capital Management, LLC held LCTX?

Connective Capital Management, LLC has disclosed LCTX holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Connective Capital Management, LLC's current position in LCTX?

As of Q3 2026, Connective Capital Management, LLC holds 293.62K shares of LCTX (LINEAGE CELL THERAPEUTICS IN), valued at $280.62K, representing 0.21% of its reported portfolio and ranking #47.

Has Connective Capital Management, LLC been buying or selling LCTX?

In the latest 13F filing (Q3 2026), Connective Capital Management, LLC newly opened its position in LCTX.

Which other funds hold LCTX?

Other major institutional holders of LCTX include BROADWOOD CAPITAL INC, Defender Capital, LLC., RAFFLES ASSOCIATES LP, among 28 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.